The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Ginkgo Bioworks Holdings Inc (NYSE: DNA) closed at $6.12 down -7.13% from its previous closing price of $6.59. In other words, the price has decreased by -$7.13 from its previous closing price. On the day, 1.5 million shares were traded. DNA stock price reached its highest trading level at $6.58 during the session, while it also had its lowest trading level at $6.105.
Ratios:
For a deeper understanding of Ginkgo Bioworks Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.62 and its Current Ratio is at 5.62. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.61.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 28 ’25 when Che Austin bought 99 shares for $6.54 per share.
Che Austin bought 99 shares of DNA for $656 on Mar 27 ’25. On Mar 26 ’25, another insider, Che Austin, who serves as the Officer of the company, bought 99 shares for $7.11 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNA now has a Market Capitalization of 355165632 and an Enterprise Value of 238903600. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.56 while its Price-to-Book (P/B) ratio in mrq is 0.44. Its current Enterprise Value per Revenue stands at 1.052 whereas that against EBITDA is -0.575.
Stock Price History:
The Beta on a monthly basis for DNA is 1.28, which has changed by -0.86339283 over the last 52 weeks, in comparison to a change of 0.06429911 over the same period for the S&P500. Over the past 52 weeks, DNA has reached a high of $48.00, while it has fallen to a 52-week low of $5.26. The 50-Day Moving Average of the stock is -40.39%, while the 200-Day Moving Average is calculated to be -38.94%.
Shares Statistics:
For the past three months, DNA has traded an average of 1.66M shares per day and 1162510 over the past ten days. A total of 42.70M shares are outstanding, with a floating share count of 36.98M. Insiders hold about 32.80% of the company’s shares, while institutions hold 57.91% stake in the company. Shares short for DNA as of 1741910400 were 9976616 with a Short Ratio of 6.02, compared to 1739491200 on 8753300. Therefore, it implies a Short% of Shares Outstanding of 9976616 and a Short% of Float of 29.43.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
